Supporting The Front Line of Our Freedom January 8, 2016 • admin • Working to better protect our military personnel from chemical nerve agent attack. Related News US CIP Patent awarded for use of galantamine as Method of Treating Organophosphorus Poisoning. April 3, 2014 Countervail holds second pre-IND meeting with Neurology Division of the FDA for guidance on development of a neuroprotectant against nerve agent exposure. February 20, 2015
